Swiss National Bank
TTPH

Swiss National Bank’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Swiss National Bank’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,310
Closed -$206K – 2615
2016
Q1 		$206K Buy
2,310
+445
+24% +$44.4K ﹤0.01% 2554
2015
Q4 		$374K Hold
1,865
– – ﹤0.01% 2399
2015
Q3 		$278K Buy
1,865
+270
+17% +$198K ﹤0.01% 2422
2015
Q2 		$1.51M Buy
1,595
+25
+2% +$20.4K ﹤0.01% 1518
2015
Q1 		$1.15M Buy
1,570
+200
+15% +$150K ﹤0.01% 1693
2014
Q4 		$1.09M Buy
+1,370
New +$738K ﹤0.01% 1679

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Swiss National Bank's TTPH Position: Q2 2016 in Review

Swiss National Bank sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 2,310 shares — an estimated $206K sold.

Swiss National Bank first reported a position in TTPH in Q4 2014 and held it in 6 quarters. The position peaked at $1.51M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • Swiss National Bank reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Swiss National Bank sold 2,310 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $206K.
  • Swiss National Bank first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 6 quarters.
  • Swiss National Bank's Tetraphase Pharmaceuticals, Inc. position peaked at $1.51M in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on Swiss National Bank's 13F filing for Q2 2016, filed 3 Aug 2016.